Diffusion-weighted magnetic resonance imaging in preoperative assessment of non– small cell lung cancer  Hiroaki Nomori, MD, Yue Cong, MD, Masaru Abe,

Slides:



Advertisements
Similar presentations
Max B. Mitchell, MD  The Journal of Thoracic and Cardiovascular Surgery 
Advertisements

Lost in translation The Journal of Thoracic and Cardiovascular Surgery
Phosphoglyceride crystal deposition disease originating from the myocardium  Fumihiro Shoji, MD, Ichiro Yoshino, MD, Takuro Kometani, MD, Hidetaka Yamamoto,
FDG PET-CT Aids in the Preoperative Assessment of Patients with Newly Diagnosed Thymic Epithelial Malignancies  Marcelo F.K. Benveniste, MD, Cesar A.
Hironori Yoshida, MD, Young Hak Kim, MD  Journal of Thoracic Oncology 
The eighth edition TNM stage classification for lung cancer: What does it mean on main street?  Frank C. Detterbeck, MD  The Journal of Thoracic and Cardiovascular.
Adenocarcinoma arising from cervical esophageal gastric inlet patch
Expanding options to manage traumatic thoracic vascular injuries
A follow-up of integrated positron emission tomography/computed tomography after curative resection of non–small-cell lung cancer in asymptomatic patients 
Qiuzhe Guo, MD, Chunyan Lu, MD, Yingqiang Guo, MD 
Pure ground glass nodular adenocarcinomas: Are preoperative positron emission tomography/computed tomography and brain magnetic resonance imaging useful.
Lung cancer screening: No more excuses
Yih-Leong Chang, MD, Chen-Tu Wu, MD, Yung-Chie Lee, MD, PhD 
Resection of Mucinous Lung Adenocarcinoma Presenting with Intractable Bronchorrhea  Motoshi Takao, MD, PhD, Takehiro Takagi, MD, Hitoshi Suzuki, MD, PhD,
The size of metastatic foci and lymph nodes yielding false-negative and false-positive lymph node staging with positron emission tomography in patients.
Multicenter analysis of high-resolution computed tomography and positron emission tomography/computed tomography findings to choose therapeutic strategies.
Unexpected Small Bowel Intussusception Caused by Lung Cancer Metastasis on 18F- Fluorodeoxyglucose PET-CT  Jeong Won Lee, MD, Seok-Ki Kim, MD, Ji Won Park,
Risk stratification for lung nodules: Size isn't everything
Ground glass opacity of the lung: The veil that needs lifting
Diffusion-Weighted Magnetic Resonance Imaging for Diagnosing Malignant Pulmonary Nodules/Masses: Comparison with Positron Emission Tomography  Takeshi.
Pattern of lymphatic spread in thoracic esophageal squamous cell carcinoma: A single- institution experience  Bin Li, MD, Haiquan Chen, MD, Jiaqing Xiang,
Form ever follows function
Systemic and regional pulmonary function after segmentectomy
Calcified amorphous tumor of left atrium
Commentary: Pursuit of the green jacket: Mastery of the long and short games  Daniel P. Raymond, MD  The Journal of Thoracic and Cardiovascular Surgery 
High-resolution computed tomography with three-dimensional reconstruction for assessment of chronic pulmonary thromboembolic disease  Thoralf M. Sundt,
STAT3, Cten, and lung cancer: Simultaneous excitement and caution
Lung adenocarcinoma: Are skip N2 metastases different from non-skip?
Yang Zhang, MD, Haiquan Chen, MD, PhD 
Metastasectomy in a lung graft using high-flow venovenous extracorporeal lung support in a patient after single lung transplantation  Bassam Redwan, MD,
Leora B. Balsam, MD  The Journal of Thoracic and Cardiovascular Surgery 
Do Complex Mutations of the Epidermal Growth Factor Receptor Gene Reflect Intratumoral Heterogeneity?  Akito Hata, MD, Shiro Fujita, MD, PhD, Reiko Kaji,
The assessment of cost effectiveness and the effectiveness of cost assessment in cardiothoracic surgery  Vinay Badhwar, MD  The Journal of Thoracic and.
It's not “just a shunt” but sometimes it should be…
Positron Emission Tomography 18F-Fluorodeoxyglucose Uptake and Prognosis in Patients with Surgically Treated, Stage I Non-small Cell Lung Cancer: A Systematic.
Respiratory dynamic magnetic resonance imaging for determining aortic invasion of thoracic neoplasms  Yoo Jin Hong, MD, Jin Hur, MD, Hye-Jeong Lee, MD,
Identification of a subcentimeter pulmonary adenocarcinoma using intraoperative near- infrared imaging during video-assisted thoracoscopic surgery  Jane.
A first start for lung transplantation?
Required area of lymph node sampling during segmentectomy for clinical stage IA non– small cell lung cancer  Hiroaki Nomori, MD, PhD, Yasuomi Ohba, MD,
The aortic valve–sparing operation
Pulmonary Metastases from Cervical Adenocarcinoma Regress to a ‘Hole’ Lot of Nothing  Michael Guandalini, MBBS (Hons), BPhty, Karin Steinke, MD, MS, PD,
Navigating the lung for hidden treasure
Impact of induction chemoradiotherapy on pulmonary function after lobectomy for lung cancer  Hiroaki Nomori, MD, Atsushi Shiraishi, MD, Yue Cong, MD,
Are discordant positron emission tomography and pathological assessments of the mediastinum in non–small cell lung cancer significant?  Daniel J. Tandberg,
Resection of primary lung cancer with incidental pleural seeding: Seeds of change or reap what you sow?  Jules Lin, MD  The Journal of Thoracic and Cardiovascular.
Leora B. Balsam, MD, Abe DeAnda, MD 
Video-assisted resection for lung cancer results in fewer complications  Lunxu Liu, PhD, MD, FRCS  The Journal of Thoracic and Cardiovascular Surgery 
We are the company we keep: The importance of the tumor microenvironment  Sai Yendamuri, MD, FACS  The Journal of Thoracic and Cardiovascular Surgery 
Passing the torch The Journal of Thoracic and Cardiovascular Surgery
Marianna Koczywas, MD, Mihaela C. Cristea, MD 
T. Brett Reece, MD  The Journal of Thoracic and Cardiovascular Surgery 
Bryan M. Burt, MD  The Journal of Thoracic and Cardiovascular Surgery 
Constantine L. Athanasuleas, MD, FACC 
Positron emission tomography predicts survival in malignant pleural mesothelioma  Raja M. Flores, MD, Timothy Akhurst, MD, Mithat Gonen, PhD, Maureen Zakowski,
The Journal of Thoracic and Cardiovascular Surgery
Discussion The Journal of Thoracic and Cardiovascular Surgery
“The more things change…”: The challenges ahead
Managing conflicts of interest
Aritoshi Hattori, MD, Kenji Suzuki, MD 
Ryan R. Davies, MD  The Journal of Thoracic and Cardiovascular Surgery 
More than vital: Who bears the burden?
Lung cancer randomized controlled trials should compare stereotactic body radiation therapy with observation, NOT surgery  Raja M. Flores, MD  The Journal.
Respect the aorta The Journal of Thoracic and Cardiovascular Surgery
Preoperative PFTs: The answer is blowing in the wind
Who should decide margin length in pulmonary excision of lung cancer?
The clinical stage of non–small cell lung cancer as assessed by means of fluorodeoxyglucose–positron emission tomographic/computed tomographic scanning.
Samuel Kim, MD  The Journal of Thoracic and Cardiovascular Surgery 
Zone zero thoracic endovascular aortic repair is all about “location, location, location”  Kevin L. Greason, MD  The Journal of Thoracic and Cardiovascular.
Reappraise the advanced technique for tumor localization and sentinel lymph node assessment in clinical early-stage non–small cell lung cancer  Chengwu.
Zipping up after a median sternotomy: Are we at the end of the wire?
Presentation transcript:

Diffusion-weighted magnetic resonance imaging in preoperative assessment of non– small cell lung cancer  Hiroaki Nomori, MD, Yue Cong, MD, Masaru Abe, MD, Hiroshi Sugimura, MD, Yoshiaki Kato, RT  The Journal of Thoracic and Cardiovascular Surgery  Volume 149, Issue 4, Pages 991-996 (April 2015) DOI: 10.1016/j.jtcvs.2015.01.019 Copyright © 2015 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Pulmonary adenocarcinoma with faint-homogenous pattern on diffusion-weighted magnetic resonance imaging. A, Computed tomography image. B, Diffusion-weighted image. The tumor is indicated in a circle. The maximum signal intensity of the tumor is 15 and the mean signal intensity of the spinal cord is 65; that is, 0.23 of signal intensity contrast ratio. C, Fluorodeoxyglucose-positron emission tomography. The tumor is indicated in a circle. The maximum standardized uptake values of the tumor and contralateral lung are 1.2 and 0.52, respectively; that is, 2.3 of the standardized uptake value contrast ratio. The Journal of Thoracic and Cardiovascular Surgery 2015 149, 991-996DOI: (10.1016/j.jtcvs.2015.01.019) Copyright © 2015 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Pulmonary adenocarcinoma with dark-homogenous pattern on diffusion-weighted magnetic resonance imaging. A, Computed tomography image. B, Diffusion-weighted image. The maximum signal intensity of the tumor is 94 and the mean signal intensity of the spinal cord is 62; that is, 1.52 of signal intensity contrast ratio. C, Fluorodeoxyglucose-positron emission tomography. The maximum standardized uptake values of tumor and contralateral lung are 4.3 and 0.67, respectively; that is, 6.3 of the standardized uptake value contrast ratio. The Journal of Thoracic and Cardiovascular Surgery 2015 149, 991-996DOI: (10.1016/j.jtcvs.2015.01.019) Copyright © 2015 The American Association for Thoracic Surgery Terms and Conditions

Figure 3 Pulmonary adenocarcinoma with heterogeneous pattern on diffusion-weighted magnetic resonance imaging. A, computed tomography image. B, Diffusion-weighted image. The maximum signal intensity of the tumor is 73 and the mean signal intensity of the spinal cord is 58; that is, 1.26 of signal intensity contrast ratio. The signal intensity contrast ratio of the dark area and faint area were 1.26 and 0.69, respectively. C, Fluorodeoxyglucose-positron emission tomography. The maximum standardized uptake values of tumor and contralateral lung are 5.8 and 0.52, respectively; that is, 11.2 of the standardized uptake ratio contrast ratio. The Journal of Thoracic and Cardiovascular Surgery 2015 149, 991-996DOI: (10.1016/j.jtcvs.2015.01.019) Copyright © 2015 The American Association for Thoracic Surgery Terms and Conditions

Figure 4 The distributions of signal intensity contrast ratio (SI-CR) in tumors with lymphatic, vascular, or pleural invasion, or lymph node metastasis and those without. The 25th percentile, median, and 75th percentile values of the former were 1.1, 1.5, and 2.23, respectively, whereas those of the latter were 0.36, 0.61, and 1.02, respectively. A central large arrow in each distribution shows median value, and the top and bottom small arrows show 75th and 25th percentile values, respectively. The Journal of Thoracic and Cardiovascular Surgery 2015 149, 991-996DOI: (10.1016/j.jtcvs.2015.01.019) Copyright © 2015 The American Association for Thoracic Surgery Terms and Conditions

Figure 5 The distributions of signal intensity contrast ratio (SI-CR) on diffusion-weighted magnetic resonance imaging in faint-homogenous (Faint-HOM), dark-homogenous (Dark-HOM), and heterogeneous (HET) tumors. The 25th percentile, median, and 75th percentile values of the faint-HOM tumors were 0.22, 0.27, and 0.36, respectively. Images that appeared dark-HOM were 0.61, 0.95, and 1.34, respectively, and those that were HET were 1.1, 1.58, and 2.42, respectively. A central large arrow in each distribution shows median value, and the top and bottom small arrows show 75th and 25th percentile values, respectively. The Journal of Thoracic and Cardiovascular Surgery 2015 149, 991-996DOI: (10.1016/j.jtcvs.2015.01.019) Copyright © 2015 The American Association for Thoracic Surgery Terms and Conditions

Figure 6 The distributions of 18F-fluorodeoxyglucose positron emission tomography uptake in faint-homogenous (Faint-HOM), dark-homogenous (Dark-HOM), and heterogeneous (HET) tumors. The 25th percentile, median, and 75th percentile values of the faint-HOM tumors were 1.4, 2.3, and 3.0, respectively. Those of dark-HOM tumors were 2.2, 4.4, and 6.5, respectively. HET tumors were 5.3, 11.2, and 16.4, respectively. A central large arrow in each distribution shows median value, and the top and bottom small arrows show 75th and 25th percentile values. The Journal of Thoracic and Cardiovascular Surgery 2015 149, 991-996DOI: (10.1016/j.jtcvs.2015.01.019) Copyright © 2015 The American Association for Thoracic Surgery Terms and Conditions